Gabather AB (publ) (STO:GABA)
Sweden · Delayed Price · Currency is SEK 0.0336
-0.0002 (-0.59%)
Aug 13, 2026, 1:39 PM CET
Gabather AB Market Cap
Gabather AB has a market cap or net worth of 20.63 million as of August 13, 2026. Its market cap has increased by 72.65% in one year.
Market Cap
20.63M
Enterprise Value
14.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since November 3, 2014, Gabather AB's market cap has decreased from 43.24M to 20.63M, a decrease of -52.28%. That is a compound annual growth rate of -6.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 20.63M | 83.93% |
| Dec 30, 2025 | 11.22M | 18.25% |
| Dec 30, 2024 | 9.49M | -54.20% |
| Dec 29, 2023 | 20.71M | -66.45% |
| Dec 30, 2022 | 61.73M | 1.64% |
| Dec 30, 2021 | 60.74M | -19.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 854.64M |
| Dicot Pharma AB | 709.69M |
| EQL Pharma AB | 679.18M |
| Cinclus Pharma Holding AB | 562.18M |
| Orexo AB | 546.17M |
| Moberg Pharma AB | 535.81M |
| Enzymatica AB | 459.98M |
| Klaria Pharma Holding AB (publ.) | 230.73M |